RhoC activation can trigger the ROCK/Lin11/Isl1/Mec3 kinase (LIMK) pathway to phosphorylate and inactivate cofilin, thereby regulating the actin cytoskeleton to regulate human glioma, squamous cell carcinoma, and breast cancer cell migration [114–118]. Here, RHOC is linked to breast cancer.